EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as Tobacco Cigarettes Substitute: A Prospective 12-Month Randomized Control Design Study

@article{Caponnetto2013EffiCiencyAS,
  title={EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as Tobacco Cigarettes Substitute: A Prospective 12-Month Randomized Control Design Study},
  author={Pasquale Caponnetto and D. Campagna and Fabio Cibella and Jaymin B. Morjaria and Massimo Caruso and Cristina Russo and Riccardo Polosa},
  journal={PLoS ONE},
  year={2013},
  volume={8}
}
Background Electronic cigarettes (e-cigarettes) are becoming increasingly popular with smokers worldwide. Users report buying them to help quit smoking, to reduce cigarette consumption, to relieve tobacco withdrawal symptoms, and to continue having a ‘smoking’ experience, but with reduced health risks. Research on e-cigarettes is urgently needed in order to ensure that the decisions of regulators, healthcare providers and consumers are based on science. Methods ECLAT is a prospective 12-month… 

Tables from this paper

Effectiveness and tolerability of electronic cigarette in real-life: a 24-month prospective observational study
TLDR
Long-term e-Cigarette use can substantially decrease cigarette consumption in smokers not willing to quit and is well tolerated.
E-cigarettes May Support Smokers With High Smoking-Related Risk Awareness to Stop Smoking in the Short Run: Preliminary Results by Randomized Controlled Trial
TLDR
The findings support the efficacy and safety of e-cigarettes in a short-term period and it could be worthwhile to associate this device with new ICT-driven models of self-management support in order to enable people to better handle behavioral changes and side effects.
Electronic Cigarettes Efficacy and Safety at 12 Months: Cohort Study
TLDR
If e-cigarette safety will be confirmed, however, the use of e-cigarettes alone may facilitate quitters remaining so, although e-smokers showed a minimal but significantly higher increase in self-rated health than other smokers.
Acute electronic cigarette use: nicotine delivery and subjective effects in regular users
TLDR
These findings demonstrate reliable blood nicotine delivery after the acute use of this brand/model of e-cigarette in a sample of regular users, and Tobacco-related withdrawal symptoms and urge to smoke were significantly reduced.
Electronic cigarettes for smoking cessation.
TLDR
The safety and effect of using ECs to help people who smoke achieve long-term smoking abstinence and the main outcome measure was abstinence from smoking after at least six months follow-up is evaluated.
E-cigarettes versus nicotine replacement treatment as harm reduction interventions for smokers who find quitting difficult: Randomised controlled trial.
TLDR
In smokers unable to quit using conventional methods, e-cigarettes were more effective than nicotine replacement therapy in facilitating validated long-term smoking reduction and smoking cessation, when limited other support was provided.
Electronic cigarettes for smoking cessation.
TLDR
There was moderate-certainty evidence, limited by imprecision, that quit rates were higher in people randomized to nicotine EC than in those randomized to Nicotine replacement therapy (NRT) and risk ratios (RRs) with a 95% confidence interval (CI) for dichotomous outcomes.
...
...

References

SHOWING 1-10 OF 50 REFERENCES
Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study
TLDR
The use of e-Cigarette substantially decreased cigarette consumption without causing significant side effects in smokers not intending to quit, and perception and acceptance of the product was good.
The emerging phenomenon of electronic cigarettes
TLDR
The health effects of using electronic cigarettes are examined, with consideration given to the acceptability, safety and effectiveness of this product to serve as a long-term substitute for smoking or as a tool for smoking cessation.
Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial
TLDR
The 16 mg Ruyan V8 ENDD alleviated desire to smoke after overnight abstinence, was well tolerated and had a pharmacokinetic profile more like the Nicorette inhalator than a tobacco cigarette.
A Clinical Laboratory Model for Evaluating the Acute Effects of Electronic “Cigarettes”: Nicotine Delivery Profile and Cardiovascular and Subjective Effects
TLDR
Under these acute testing conditions, neither of the electronic cigarettes exposed users to measurable levels of nicotine or CO, although both suppressed nicotine/tobacco abstinence symptom ratings and increased product acceptability ratings.
Saliva cotinine levels in users of electronic cigarettes
TLDR
ENDS do attenuate craving for tobacco, but appear to deliver little nicotine to the blood, and it is possible that serum nicotine levels would have been similar in ENDS and inhaler users, had ENDS users been allowed to use the devices for 20 min as for the inhaler.
Randomised trial investigating effect of a novel nicotine delivery device (Eclipse) and a nicotine oral inhaler on smoking behaviour, nicotine and carbon monoxide exposure, and motivation to quit
TLDR
Eclipse can dramatically decrease cigarette consumption without causing withdrawal symptoms or decreases in nicotine concentrations or motivation to quit altogether, and Eclipse may not be a safer cigarette.
Electronic nicotine delivery systems: a research agenda
TLDR
The authors, who cover a broad range of scientific expertise, from basic science to public health, suggest research priorities for non-clinical, clinical and public health studies, and conclude that the first priority is to characterize the safety profile of these products, including in long-term users.
Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy.
TLDR
E-cigarettes were used much as people would use nicotine replacement medications: by former smokers to avoid relapse or as an aid to cut down or quit smoking, and for quitting and relapse prevention.
Effect of a nicotine-free inhalator as part of a smoking-cessation programme
TLDR
The results of the logistic model analysis indicate that a high GN-SBQ score is a strong independent predictor for successful quitting at 24 weeks in the PAIPO group, and nicotine-free inhalators may be beneficial when used in the context of smoking-cessation interventions.
...
...